Saba Capital Management, Reported A 5.31% Stake In abrdn Life Sciences
$HQL
Investment Managers
Finance
-13D
-13D
Save time and jump to the most important pieces.
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
N-PX - abrdn Life Sciences Investors (0000884121) (Filer)
N-CSRS - abrdn Life Sciences Investors (0000884121) (Filer)
NPORT-P - abrdn Life Sciences Investors (0000884121) (Filer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:FAX)(NYSE:FCO)(NYSE:IAF)(NYSE:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equi
PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:HQH)(NYSE:HQL)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 28, 2024, on a per share basis to all shareholders of record as of June 21, 2024 (ex-dividend date June 21, 2024). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and abrdn Japan Equity Fund, Inc. (JEQ) which will pay on June 28, 2024, to al
PHILADELPHIA, PA / ACCESSWIRE / February 9, 2024 / abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) (collectively, the "Funds") each, a closed-end management investment company, announced today its Board of Trustees (each a "Board" and collectively, the "Boards") have approved an increase in each Fund's respective distribution rate and announce payment details for the Funds in the chart directly below.TickerExchangeFundDistribution Policy PreviousDistribution Policy NewDeclared DistributionAmountHQHNYSEabrdn Healthcare InvestorsAnnualized rate of 8% of rolling NAVAnnualized rate of 10% of rolling NAV$ 0.4800HQLNYSEabrdn Life
SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)
SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)
SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)
PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:FAX)(NYSE:FCO)(NYSE:IAF)(NYSE:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equi
PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:HQH)(NYSE:HQL)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 28, 2024, on a per share basis to all shareholders of record as of June 21, 2024 (ex-dividend date June 21, 2024). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and abrdn Japan Equity Fund, Inc. (JEQ) which will pay on June 28, 2024, to al
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has
Although U.S. stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform. Lake Shore Bancorp The Trade: Lake Shore Bancorp, Inc. (NASDAQ:LSBK) Director Kevin M. Sanvidge acquired a total of 3,000 sh
-13D
During the session on Thursday, 461 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was Pfizer (NYSE:PFE). The smallest company by market cap to set a new 52-week low was Akerna (NASDAQ:KERN). PolyPid (NASDAQ:PYPD) saw the most significant move of the companies, as shares traded down 2315.34% to reach its new 52-week low. Frontier Group Holdings (NASDAQ:ULCC) shares rebounded the highest, with shares trading up 0.0%, bouncing back after reaching its new 52-week low. The stocks that set new 52-week lows on Thursday: Diageo (NYSE:DEO) shares fell to $156.42 on Thursday, setting a new 52